AOP Orphan Pharmaceuticals GmbH (AOP Health), based in Vienna, Austria, announced that the U.S. Food and Drug Administration (FDA) has granted regulatory approval for Rapiblyk(TM) (landiolol) in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback